honestabe13, i am in PPHM since 15 years now and build a big position (also many people i know have PPHM positions). I am here on IHub posting since several years.
I vote YES and so will those around me.
All invested knowing that it would take 10/15 years to get approved and so could know how many years they would have to wait before getting any perspective based on the date they got in.
In 2012 we were actually ahead on schedule. Due to the dose switching incidents and the related delay it will be in 2016. But fine, planning that is NOT exact science. Some predicted that it would delay us 4 years. It clearly didn't, the FDA approved the salvaged data in 2013 and SUNRISE started that same year in DEC. So without the dose switching we would have started a little sooner and possible with about 100 patients to enrol less.
I don't see why now that the company is in its best shape ever and we are 21 months into a MAX 36 months clinical trial SUNRISE to get PIII approval, with 2 look-ins and therefore even possibilities to cut part of those 36 months, i should start to handicap the company by going against there advice.
I never did that in the past and it got us exactly where we all want to be: a STEP away from getting a PIII approval for Bavituximab.
And we OWN bavituximab's pipelines and IP 100%. That is frankly BETTER then I expected because PRE Sept 2012 i was, probably like most on here, expecting part of our pipeline/PPHM to get owned by a partner in old suffocating style.
Yes I know, the PPS 1:11$, in Q1/2012 it was about 0.60$ after long slow decline while waiting for results. On Friday Sept 21th 2012 it closed 5.40$. In Q4/2011 and Q1/2012 it was also said: Look at the PPS 0.60$ Says it all.
Apparently not.
Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.
